Skip to content
Research Article Open access CC BY 4.0

Future-oriented and Progress in DNA Vaccine and Delivery Systems for the Treatment of Human Diseases

Shivani Biragi, Satish Dod, Tejas Singh, Upendra Prajapati, Shaily Chaudhary

Asian Journal of Research in Medical and Pharmaceutical Sciences · pp. 94–108 · Published 22 Jul 2024

10.9734/ajrimps/2024/v13i3265

Abstract

In the domain of vaccination, DNA antibodies have transformed into a striking methodology that appreciates different high grounds over ordinary vaccination modalities. A design of the vital considerations behind DNA vaccinations, their technique for action, and energy upgrades in their assessment are given in this hypothetical. Trustworthy immunity is made by DNA courses of action, which use plasmid DNA encoding antigenic proteins to move humoral and cell-safe responses. They are in like manner a secured and versatile stage for immunization considering their capacity to replicate a trademark illness without spreading disorder. DNA inoculations are dynamic against different versatile contaminations, including those achieved by microorganisms, diseases, and parasite organisms. Furthermore, updates in adjuvants, plan frameworks, and association techniques have raised their immunogenicity and adequacy. Notwithstanding the way that there have been a couple of sure new developments, enormous checks really ought to be addressed to redesign power." DNA inoculations, by and large, address a promising street for making state-of-the-art antibodies arranged to effectively fight emerging overwhelming risks.

DNA vaccine carries adjuvants plasmid bacteria covid mirna antibody immune response

References (31)

  1. 1 Direct Gene Transfer into Mouse Muscle in Vivo [DOI]
  2. 2 DNA vaccines: ready for prime time? [DOI]
  3. 3 First Human Trial of a DNA-Based Vaccine for Treatment of Human Immunodeficiency Virus Type 1 Infection: Safety and Host Response [DOI]
  4. 4 DNA Vaccines: Progress and Challenges [DOI]
  5. 5 DNA vaccines: precision tools for activating effective immunity against cancer [DOI]
  6. 6 DNA and RNA-based vaccines: principles, progress and prospects [DOI]
  7. 7 Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine [DOI]
  8. 8 Plasmid DNA vaccine vector design: Impact on efficacy, safety and upstream production [DOI]
  9. 9 DNA Vaccination with Electroporation Induces Increased Antibody Responses in Patients with Prostate Cancer [DOI]
  10. 10 Vector Design for Improved DNA Vaccine Efficacy, Safety and Production [DOI]
  11. 11 Lactic acid bacteria—20 years exploring their potential as live vectors for mucosal vaccination [DOI]
  12. 12 The past, current and future trends in DNA vaccine immunisations [DOI]
  13. 13 An Improved Plasmid DNA Expression Vector for Direct Injection into Skeletal Muscle [DOI]
  14. 14 Antigen Presentation Pathways to Class I and Class II MHC‐Restricted T Lymphocytes [DOI]
  15. 15 Intranasal DNA Vaccination Induces Potent Mucosal and Systemic Immune Responses and Cross-protective Immunity Against Influenza Viruses [DOI]
  16. 16 Live bacterial vaccine vectors: An overview [DOI]
  17. 17 New technologies in developing recombinant attenuated Salmonella vaccine vectors [DOI]
  18. 18 Plasmid DNA vaccines: where are we now? [DOI]
  19. 19 Live Bacterial Vectors—A Promising DNA Vaccine Delivery System [DOI]
  20. 20 Immune responses to DNA vaccines [DOI]
  21. 21 Safety and Immunogenicity of DNA/Modified Vaccinia Virus Ankara Malaria Vaccination in African Adults [DOI]
  22. 22 Listeria as a vaccine vector [DOI]
  23. 23 Duration of Antigen Expression In Vivo following DNA Immunization Modifies the Magnitude, Contraction, and Secondary Responses of CD8+ T Lymphocytes [DOI]
  24. 24 Cryptic transcripts from a ubiquitous plasmid origin of replication confound tests for cis-regulatory function [DOI]
  25. 25 pDNAVACCultra vector family: high throughput intracellular targeting DNA vaccine plasmids [DOI]
  26. 26 Immunogenicity of an HIV-1 gag DNA vaccine carried by attenuated Shigella [DOI]
  27. 27 Advances in the Adverse Effects of Covid-19 Vaccination and the Concept of Vaccine Development [DOI]
  28. 28 Rates and Predictors for Influenza Vaccine Prescriptions Among HIV-infected Clinic Patients in Singapore [DOI]
  29. 29 Genetic Immunization: Bacteria as DNA Vaccine Delivery Vehicles [DOI]
  30. 30 Cellular immune response to cryptic epitopes during therapeutic gene transfer [DOI]
  31. 31 Frequency of Symptoms of COVID-19 Disease among the People of Bangladesh [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

53

Page views

0

PDF downloads

17

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.